YMC017

· Yuhan Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YMC017, covering 2019-04-12 to 2019-04-12. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome [Phase 4]